Rakovina Therapeutics Inc (TSE:RKV) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Rakovina Therapeutics Inc. announced its participation in the 13th Annual Tumour Models London Summit, where it will showcase its innovative cancer treatment research. Prof. Mads Daugaard, the company’s president, will present the development of 3D bioprinted bone mimics for drug screening and cancer research. The summit is a platform for sharing advanced insights into drug discovery and cancer therapy.
For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue